{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:35:28Z","timestamp":1773747328074,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1H1A2079721"],"award-info":[{"award-number":["NRF-2019R1H1A2079721"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010446","name":"Institute for Basic Science","doi-asserted-by":"crossref","award":["IBS-R015-D1"],"award-info":[{"award-number":["IBS-R015-D1"]}],"id":[{"id":"10.13039\/501100010446","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The age at onset (AAO) is an important determinant in Parkinson\u2019s disease (PD). Neuroimaging genetics is suitable for studying AAO in PD as it jointly analyzes imaging and genetics. We aimed to identify features associated with AAO in PD by applying the objective-specific neuroimaging genetics approach and constructing an AAO prediction model. Our objective-specific neuroimaging genetics extended the sparse canonical correlation analysis by an additional data type related to the target task to investigate possible associations of the imaging\u2013genetic, genetic\u2013target, and imaging\u2013target pairs simultaneously. The identified imaging, genetic, and combined features were used to construct analytical models to predict the AAO in a nested five-fold cross-validation. We compared our approach with those from two feature selection approaches where only associations of imaging\u2013target and genetic\u2013target were explored. Using only imaging features, AAO prediction was accurate in all methods. Using only genetic features, the results from other methods were worse or unstable compared to our model. Using both imaging and genetic features, our proposed model predicted the AAO well (r\u2009=\u20090.5486). Our findings could have significant impacts on the characterization of prodromal PD and contribute to diagnosing PD early because genetic features could be measured accurately from birth.<\/jats:p>","DOI":"10.1038\/s41598-020-68301-x","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T10:04:02Z","timestamp":1594807442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prediction of age at onset in Parkinson\u2019s disease using objective specific neuroimaging genetics based on a sparse canonical correlation analysis"],"prefix":"10.1038","volume":"10","author":[{"given":"Ji Hye","family":"Won","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyoung","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"68301_CR1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3988\/jcn.2016.12.4.393","volume":"12","author":"D-Y Kwon","year":"2016","unstructured":"Kwon, D.-Y. et al. The KMDS-NATION study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson\u2019s Disease NATION Study Group. J. Clin. Neurol. 12, 393 (2016).","journal-title":"J. Clin. Neurol."},{"key":"68301_CR2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/mds.10527","volume":"18","author":"A Schrag","year":"2003","unstructured":"Schrag, A., Hovris, A., Morley, D., Quinn, N. & Jahanshahi, M. Young- versus older-onset Parkinson\u2019s disease: Impact of disease and psychosocial consequences. Mov. Disord. 18, 1250\u20131256 (2003).","journal-title":"Mov. Disord."},{"key":"68301_CR3","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1212\/WNL.0000000000002461","volume":"86","author":"G Pagano","year":"2016","unstructured":"Pagano, G., Ferrara, N., Brooks, D. J. & Pavese, N. Age at onset and Parkinson disease phenotype. Neurology 86, 1400\u20131407 (2016).","journal-title":"Neurology"},{"key":"68301_CR4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1468-1331.2008.02514.x","volume":"16","author":"MM Wickremaratchi","year":"2009","unstructured":"Wickremaratchi, M. M., Ben-Shlomo, Y. & Morris, H. R. The effect of onset age on the clinical features of Parkinson\u2019s disease. Eur. J. Neurol. 16, 450\u2013456 (2009).","journal-title":"Eur. J. Neurol."},{"key":"68301_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000484249","volume":"18","author":"HR Park","year":"2018","unstructured":"Park, H. R. et al. Characteristic motor and nonmotor symptoms related to quality of life in drug-Na\u00efve patients with late-onset Parkinson disease. Neurodegener. Dis. 18, 19\u201325 (2018).","journal-title":"Neurodegener. Dis."},{"key":"68301_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000022147","volume":"46","author":"H Nagayama","year":"2000","unstructured":"Nagayama, H. et al. Initial symptoms of Parkinson\u2019s disease with elderly onset. Gerontology 46, 129\u2013132 (2000).","journal-title":"Gerontology"},{"key":"68301_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archneur.60.4.529","volume":"60","author":"NJ Diederich","year":"2003","unstructured":"Diederich, N. J., Moore, C. G., Leurgans, S. E., Chmura, T. A. & Goetz, C. G. Parkinson disease with old-age onset. Arch. Neurol. 60, 529 (2003).","journal-title":"Arch. Neurol."},{"key":"68301_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jhg.2010.13","volume":"55","author":"TH Hamza","year":"2010","unstructured":"Hamza, T. H. & Payami, H. The heritability of risk and age at onset of Parkinson\u2019s disease after accounting for known genetic risk factors. J. Hum. Genet. 55, 241\u2013243 (2010).","journal-title":"J. Hum. Genet."},{"key":"68301_CR9","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1093\/hmg\/ddw206","volume":"25","author":"EM Hill-Burns","year":"2016","unstructured":"Hill-Burns, E. M. et al. Identification of genetic modifiers of age-at-onset for familial Parkinson\u2019s disease. Hum. Mol. Genet. 25, 3849\u20133862 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"68301_CR10","first-page":"611","volume":"7","author":"S Marino","year":"2012","unstructured":"Marino, S. et al. Magnetic resonance imaging markers for early diagnosis of Parkinson\u2019s disease. Neural Regener. Res. 7, 611\u2013619 (2012).","journal-title":"Neural Regener. Res."},{"key":"68301_CR11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00702-017-1717-8","volume":"124","author":"B Heim","year":"2017","unstructured":"Heim, B., Krismer, F., De Marzi, R. & Seppi, K. Magnetic resonance imaging for the diagnosis of Parkinson\u2019s disease. J. Neural Transm. 124, 915\u2013964 (2017).","journal-title":"J. Neural Transm."},{"key":"68301_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27931","author":"N Betrouni","year":"2019","unstructured":"Betrouni, N., Lopes, R., Defebvre, L., Leentjens, A. F. G. & Dujardin, K. Texture features of magnetic resonance images: A marker of slight cognitive deficits in Parkinson\u2019s disease. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.27931 (2019).","journal-title":"Mov. Disord."},{"key":"68301_CR13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nicl.2017.07.011","volume":"16","author":"C Atkinson-Clement","year":"2017","unstructured":"Atkinson-Clement, C., Pinto, S., Eusebio, A. & Coulon, O. Diffusion tensor imaging in Parkinson\u2019s disease: Review and meta-analysis. NeuroImage Clin. 16, 98\u2013110 (2017).","journal-title":"NeuroImage Clin."},{"key":"68301_CR14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01249445","volume":"38","author":"P Riederer","year":"1976","unstructured":"Riederer, P. & Wuketich, S. Time course of nigrostriatal degeneration in parkinson\u2019s disease. A detailed study of influential factors in human brain amine analysis. J. Neural Transm. 38, 277\u2013301 (1976).","journal-title":"J. Neural Transm."},{"key":"68301_CR15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek, K. et al. The Parkinson progression marker initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"68301_CR16","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","volume":"27","author":"P Danecek","year":"2011","unstructured":"Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27, 2156\u20132158 (2011).","journal-title":"Bioinformatics"},{"key":"68301_CR17","unstructured":"ENIGMA2 Genetics Support Team. ENIGMA2 1KGP Cookbook (v3) [Online]. The Enhancing Neuroimaging Genetics through MetaAnalysis (ENIGMA) Consortium. https:\/\/enigma.ini.usc.edu\/wp-content\/uploads\/2012\/07\/ENIGMA2_1KGP_cookbook_v3.pdf (2013)."},{"key":"68301_CR18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"68301_CR19","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith, S. M. et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23, S208\u2013S219 (2004).","journal-title":"Neuroimage"},{"key":"68301_CR20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11065-015-9291-z","volume":"25","author":"BA Mueller","year":"2015","unstructured":"Mueller, B. A., Lim, K. O., Hemmy, L. & Camchong, J. Diffusion MRI and its role in neuropsychology. Neuropsychol. Rev. 25, 250\u2013271 (2015).","journal-title":"Neuropsychol. Rev."},{"key":"68301_CR21","doi-asserted-by":"crossref","first-page":"44272","DOI":"10.1038\/srep44272","volume":"7","author":"X Hao","year":"2017","unstructured":"Hao, X. et al. Mining outcome-relevant brain imaging genetic associations via three-way sparse canonical correlation analysis in Alzheimer\u2019s disease. Sci. Rep. 7, 44272 (2017).","journal-title":"Sci. Rep."},{"key":"68301_CR22","doi-asserted-by":"crossref","first-page":"Article28","DOI":"10.2202\/1544-6115.1470","volume":"8","author":"DM Witten","year":"2009","unstructured":"Witten, D. M. & Tibshirani, R. J. Extensions of sparse canonical correlation analysis with applications to genomic data. Stat. Appl. Genet. Mol. Biol. 8, Article28 (2009).","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"68301_CR23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00477-016-1322-7","volume":"31","author":"KS Cheng","year":"2017","unstructured":"Cheng, K. S., Lien, Y. T., Wu, Y. C. & Su, Y. F. On the criteria of model performance evaluation for real-time flood forecasting. Stoch. Environ. Res. Risk Assess. 31, 1123\u20131146 (2017).","journal-title":"Stoch. Environ. Res. Risk Assess."},{"key":"68301_CR24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbadis.2008.09.009","volume":"1792","author":"TA Yacoubian","year":"2009","unstructured":"Yacoubian, T. A. & Standaert, D. G. Targets for neuroprotection in Parkinson\u2019s disease. Biochim. Biophys. Acta Mol. Basis Dis. 1792, 676\u2013687 (2009).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"68301_CR25","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.0b013e3182a6cbd5","volume":"81","author":"B Mollenhauer","year":"2013","unstructured":"Mollenhauer, B. et al. Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 81, 1226\u20131234 (2013).","journal-title":"Neurology"},{"key":"68301_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","volume":"30","author":"C Pont-Sunyer","year":"2015","unstructured":"Pont-Sunyer, C. et al. The onset of nonmotor symptoms in Parkinson\u2019s disease (The ONSET PDStudy). Mov. Disord. 30, 229\u2013237 (2015).","journal-title":"Mov. Disord."},{"key":"68301_CR27","doi-asserted-by":"crossref","first-page":"16866","DOI":"10.1038\/s41598-018-35376-6","volume":"8","author":"J Youn","year":"2018","unstructured":"Youn, J. et al. Cerebrospinal fluid levels of autophagy-related proteins represent potentially novel biomarkers of early-stage Parkinson\u2019s disease. Sci. Rep. 8, 16866 (2018).","journal-title":"Sci. Rep."},{"key":"68301_CR28","first-page":"1277","volume":"70","author":"J-H Kang","year":"2013","unstructured":"Kang, J.-H. et al. Association of cerebrospinal fluid \u03b2-amyloid 1\u201342, T-tau, P-tau181, and \u03b1-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol. 70, 1277\u20131287 (2013).","journal-title":"JAMA Neurol."},{"key":"68301_CR29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","volume":"13","author":"CR Jack","year":"2014","unstructured":"Jack, C. R. et al. Age-specific population frequencies of cerebral \u03b2-amyloidosis and neurodegeneration among people with normal cognitive function aged 50\u201389 years: A cross-sectional study. Lancet. Neurol. 13, 997\u20131005 (2014).","journal-title":"Lancet. Neurol."},{"key":"68301_CR30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat. Genet. 46, 989 (2014).","journal-title":"Nat. Genet."},{"key":"68301_CR31","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake, W. et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat. Genet. 41, 1303\u20131307 (2009).","journal-title":"Nat. Genet."},{"key":"68301_CR32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JPD-171240","volume":"7","author":"K Thirtamara-Rajamani","year":"2017","unstructured":"Thirtamara-Rajamani, K. et al. Is the enzyme ACMSD a novel therapeutic target in Parkinson\u2019s disease?. J. Parkinson\u2019s Dis. 7, 577\u2013587 (2017).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"68301_CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/187152712800672463","volume":"11","author":"F Sambataro","year":"2012","unstructured":"Sambataro, F., Pennuto, M. & ChristianWolf, R. Catechol-O-methyl transferase modulates cognition in late life: evidence and implications for cognitive enhancement. CNS Neurol. Disord. Drug Targets 11, 195\u2013208 (2012).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"68301_CR34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/jnnp-2012-304475","volume":"84","author":"S Klebe","year":"2013","unstructured":"Klebe, S. et al. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson\u2019s disease with a sexual dimorphism. J. Neurol. Neurosurg. Psychiatry 84, 666\u2013673 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"68301_CR35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fgene.2019.00020","volume":"10","author":"C Tang","year":"2019","unstructured":"Tang, C. et al. Meta-analysis of the effects of the catechol-O-methyltransferase Val158\/108Met polymorphism on Parkinson\u2019s disease susceptibility and cognitive dysfunction. Front. Genet. 10, 20 (2019).","journal-title":"Front. Genet."},{"key":"68301_CR36","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/cercor\/bhh032","volume":"14","author":"DH Salat","year":"2004","unstructured":"Salat, D. H. et al. Thinning of the cerebral cortex in aging. Cereb. Cortex 14, 721\u2013730 (2004).","journal-title":"Cereb. Cortex"},{"key":"68301_CR37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/1874609811104030192","volume":"4","author":"CB Clark","year":"2012","unstructured":"Clark, C. B. & Taylor, L. J. Age-related changes in motor cortical properties and voluntary activation of skeletal muscle. Curr. Aging Sci. 4, 192\u2013199 (2012).","journal-title":"Curr. Aging Sci."},{"key":"68301_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2017.11.064","volume":"675","author":"X-R Li","year":"2018","unstructured":"Li, X.-R., Ren, Y.-D., Cao, B. & Huang, X.-L. Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson\u2019s disease. Neurosci. Lett. 675, 127\u2013132 (2018).","journal-title":"Neurosci. Lett."},{"key":"68301_CR39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3174\/ajnr.A2372","volume":"32","author":"SH Lee","year":"2011","unstructured":"Lee, S. H. et al. Regional volume analysis of the Parkinson disease brain in early disease stage: Gray matter, white matter, striatum, and thalamus. Am. J. Neuroradiol. 32, 682\u2013687 (2011).","journal-title":"Am. J. Neuroradiol."},{"key":"68301_CR40","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.parkreldis.2015.10.017","volume":"21","author":"SY Liu","year":"2015","unstructured":"Liu, S. Y. et al. Onset-related subtypes of Parkinson\u2019s disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study. Park. Relat. Disord. 21, 1448\u20131453 (2015).","journal-title":"Park. Relat. Disord."},{"key":"68301_CR41","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1073\/pnas.98.4.1930","volume":"98","author":"CH Jiang","year":"2001","unstructured":"Jiang, C. H., Tsien, J. Z., Schultz, P. G. & Hu, Y. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl. Acad. Sci. USA 98, 1930\u20131934 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68301_CR42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14802\/jmd.18064","volume":"12","author":"SJ Chung","year":"2019","unstructured":"Chung, S. J., Yoo, H. S., Lee, Y. H., Lee, P. H. & Sohn, Y. H. Heterogeneous patterns of striatal dopamine loss in patients with young- versus old-onset Parkinson\u2019s disease: Impact on clinical features. J. Mov. Disord. 12, 113\u2013119 (2019).","journal-title":"J. Mov. Disord."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68301-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68301-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68301-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:02:13Z","timestamp":1670335333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68301-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68301"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68301-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]},"assertion":[{"value":"5 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11662"}}